Affiliation:
1. Departamento de Neurobiologia del Desarrollo y Neurofisiologia, Instituto de Neurobiologia, Universidad Nacional Autonoma de Mexico, Queretaro, Qro., 76230, Mexico
Abstract
A variety of neurological diseases, including Alzheimer’s disease (AD), involve amyloid beta (Aβ) accumulation and/or neuroinflammation, which can alter synaptic and neural circuit functions. Consequently, these pathological conditions induce changes in neural network rhythmic activity (brain arrhythmias), which affects many brain functions. Neural network rhythms are involved in information processing, storage and retrieval, which are essential for memory consolidation, executive functioning and sensory processing. Therefore, brain arrhythmias could have catastrophic effects on circuit function, underlying the symptoms of various neurological diseases. Moreover, brain arrhythmias can serve as biomarkers for a variety of brain diseases. The aim of this review is to provide evidence linking Aβ and inflammation to neural network dysfunction, focusing on alterations in brain rhythms and their impact on cognition and sensory processing. I reviewed the most common brain arrhythmias characterized in AD, in AD transgenic models and those induced by Aβ. In addition, I reviewed the modulations of brain rhythms in neuroinflammatory diseases and those induced by immunogens, interleukins and microglia. This review reveals that Aβ and inflammation produce a complex set of effects on neural network function, which are related to the induction of brain arrhythmias and hyperexcitability, both closely related to behavioral alterations. Understanding these brain arrhythmias can help to develop therapeutic strategies to halt or prevent these neural network alterations and treat not only the arrhythmias but also the symptoms of AD and other inflammation-related pathologies.
Funder
Consejo Nacional de Ciencia y Tecnología
Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de Méxic
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Neurology,Neurology
Reference343 articles.
1. Qiu C.; Kivipelto M.; von Strauss E.; Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009).,11(2),111-128
2. Ittner L.M.; Götz J.; Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci (2011).,12(2),65-72
3. Heneka M.T.; Kummer M.P.; Latz E.; Innate immune activation in neurodegenerative disease. Nat Rev Immunol (2014).,14(7),463-477
4. Heneka M.T.; Golenbock D.T.; Latz E.; Innate immunity in Alzheimer’s disease. Nat Immunol (2015).,16(3),229-236
5. Mondragón-Rodríguez S.; Perry G.; Peña-Ortega F.; Williams S.; Tau, amyloid beta and deep brain stimulation: aiming to restore cognitive deficit in Alzheimer’s disease. Curr Alzheimer Res (2017).,14(1),40-46
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献